Subscribe to RSS

DOI: 10.1055/s-0045-1814092
Senkyunolide A Attenuates OGD/R-Induced HT22 Cell Injury by Inhibiting Oxidative Stress and Apoptosis
Authors
Funding This study was supported by the National Natural Science Foundation of China (82574916) and the Joint Fund of Henan Province (232301420018).
Abstract
Objective
This study aimed to investigate the protective effect and mechanism of Senkyunolide A (SenA) on oxygen-glucose deprivation/reoxygenation (OGD/R)-induced injury in mouse hippocampal neuronal HT22 cells, providing experimental evidence for elucidating the application of SenA in the prevention and treatment of cerebral ischemia–reperfusion injury.
Methods
An HT22 cell injury model was established using the OGD/R method and divided into the Control group, Model (OGD/R) group, Edaravone (EDA) group (OGD/R + EDA), and SenA group (OGD/R + SenA). Cell viability was detected by Cell counting kit-8 (CCK-8) assay; live and dead cells were observed by Calcein AM/PI cell viability assay kit (Calcein-AM/PI) double staining; intracellular reactive oxygen species (ROS) levels were measured using the H2DCFDA (DCFH-DA) fluorescent probe; levels of malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione (GSH) were determined by biochemical kits; apoptosis rate was detected by flow cytometry; protein expression levels of Bcl-2-associated X protein (Bax), B-cell lymphoma 2 (Bcl-2), and Cysteine-dependent aspartate-specific protease-3 (Caspase-3) were measured by Western blot.
Results
Compared with the Control group, the OGD/R group showed significantly reduced cell viability (p < 0.001), increased proportions of dead cells, ROS and MDA levels, and apoptosis rate (p < 0.001), decreased SOD activity and GSH levels (p < 0.05; p < 0.001), significantly upregulated protein expression of Bax and Caspase-3 (p < 0.01; p < 0.001), and downregulated Bcl-2 expression (p < 0.001). Compared with the OGD/R group, both SenA and EDA significantly increased cell viability (p < 0.001), reduced the proportion of dead cells, ROS and MDA levels, and apoptosis rate (p < 0.001), upregulated SOD activity and GSH levels (p < 0.01; p < 0.001), downregulated protein expression of Bax and Caspase-3 (p < 0.01; p < 0.001), and upregulated Bcl-2 expression (p < 0.001).
Conclusion
SenA can alleviate OGD/R-induced neuronal injury by mitigating oxidative stress and inhibiting cell apoptosis. This study provides modern experimental evidence for the traditional theory of Chuanxiong in “promoting blood circulation, removing blood stasis, and unblocking brain collaterals,” and offers new insights for the prevention and treatment of ischemia–reperfusion brain injury with traditional Chinese medicine.
Keywords
ischemic stroke - senkyunolide A - oxygen-glucose deprivation/reoxygenation - oxidative stress - apoptosisCRediT Authorship Contribution Statement
Roujia Guo: Methodology, investigation, visualization, and writing original draft. Yufang Zhao: Investigation, and data curation. Zhouli Yue: Conceptualization, investigation, formal analysis, and visualization. Yucheng Li: Project administration, supervision, conceptualization, funding acquisition, and writing-review & editing.
Publication History
Received: 21 July 2025
Accepted: 17 September 2025
Article published online:
30 December 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Zhao SY, Zhang H, Shao XX. et al. Progress on pharmacological mechanism of Chinese medicine Chuanxiong (Chuanxiong Rhizoma) in cerebral ischemic stroke. Liaoning Zhongyiyao Daxue Xuebao 2024; 26 (09) 185-189
- 2 Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies. Exp Neurol 2021; 335: 113518
- 3 Walter K. What is acute ischemic stroke?. JAMA 2022; 327 (09) 885
- 4 Li W, Xu P, Kong L. et al. Elabela-APJ axis mediates angiogenesis via YAP/TAZ pathway in cerebral ischemia/reperfusion injury. Transl Res 2023; 257: 78-92
- 5 Shen M, Zheng Y, Li G. et al. Dual antioxidant DH-217 mitigated cerebral ischemia–reperfusion injury by targeting IKKβ/Nrf2/HO-1 signal axis. Neurochem Res 2023; 48 (02) 579-590
- 6 Liu K, Zhou Y, Song X. et al. Baicalin attenuates neuronal damage associated with SDH activation and PDK2-PDH axis dysfunction in early reperfusion. Phytomedicine 2024; 129: 155570
- 7 Yuan Q, Yuan Y, Zheng Y. et al. Anti-cerebral ischemia reperfusion injury of polysaccharides: A review of the mechanisms. Biomed Pharmacother 2021; 137: 111303
- 8 Zhou S, Gao X, Chen C. et al. Porcine cardiac blood - Salvia miltiorrhiza root alleviates cerebral ischemia reperfusion injury by inhibiting oxidative stress induced apoptosis through PI3K/AKT/Bcl-2/Bax signaling pathway. J Ethnopharmacol 2023; 316: 116698
- 9 Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N. Neuroprotective effects of edaravone: A novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 2006; 12 (01) 9-20
- 10 Lyu SX, Qian DF, Feng YF. et al. Safety of butylphthalide and edaravone in patients with ischemic stroke: A multicenter real-world study. J Geriatr Cardiol 2023; 20 (04) 293-308
- 11 Chan SS, Cheng TY, Lin G. Relaxation effects of ligustilide and senkyunolide A, two main constituents of Ligusticum chuanxiong, in rat isolated aorta. J Ethnopharmacol 2007; 111 (03) 677-680
- 12 Shao M, Lv D, Zhou K, Sun H, Wang Z. Senkyunolide A inhibits the progression of osteoarthritis by inhibiting the NLRP3 signalling pathway. Pharm Biol 2022; 60 (01) 535-542
- 13 Lin H. Protective effect of senkyunolide A against rats cerebral ischemia-reperfusion injury. J North Pharm 2016; 13: 114-115
- 14 Zhang Q, Wang Y, Xiu Y. et al. Senkyunolide A attenuates cerebral ischemia-reperfusion injury by inhibiting NLRP3-mediated ferroptosis in PC12 cells. Gen Physiol Biophys 2025; 44 (01) 51-61
- 15 Guo R, Quan S, Liu Y. et al. Protective effects of atractylenolide III on oxygen-glucose-deprivation/reperfusion-induced injury in HT22 cells. Hum Exp Toxicol 2024; 43: 96 03271241288508
- 16 Wan J, Xiao T. MiR-1224 downregulation inhibits OGD/R-induced hippocampal neuron apoptosis through targeting Ku protein. Metab Brain Dis 2022; 37 (02) 531-543
- 17 Jin GY, Jin LL, He JB. The pathological complexity of stroke and rational treatment principles of Chinese herbal medicine. Chin Med Natural Prod 2025; 5 (01) 1-22
- 18 Qiao S, Yang D, Li X, Li W, Zhang Y, Liu W. Silencing PAQR3 protects against oxygen-glucose deprivation/reperfusion-induced neuronal apoptosis via activation of PI3K/AKT signaling in PC12 cells. Life Sci 2021; 265: 118806
- 19 Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol 2022; 221 (06) e202201159
- 20 Huang Q, Zhang C, Dong S. et al. Asafoetida exerts neuroprotective effect on oxidative stress induced apoptosis through PI3K/Akt/GSK3β/Nrf2/HO-1 pathway. Chin Med 2022; 17 (01) 83
- 21 Tan Y, Zhou F, Yang D, Zhang X, Zeng M, Wan L. MicroRNA-126a-5p exerts neuroprotective effects on ischemic stroke via targeting NADPH oxidase 2. Neuropsychiatr Dis Treat 2021; 17: 2089-2103
- 22 Zhang J, Ma YZ. Effect of Fuzhi capsule on apoptotic timing of hippocampal neurons in rats with vascular dementia. Acta Chin Med 2019; 34 (03) 551-554
- 23 Guan Y, Wan Z, Wang S. et al. Combination of components from Tripterygii Radix et Rhizoma-Chuanxiong Rhizoma affects RA-FLSs by regulating NF-κB, Nrf2/HO-1 signaling pathways and Bcl-2/Caspase-3 expression. Chin J Exp Tradit Med Formul 2025; 17-26
- 24 Bortner CD, Oakley RH, Cidlowski JA. Overcoming apoptotic resistance afforded by Bcl-2 in lymphoid tumor cells: A critical role for dexamethasone. Cell Death Discov 2022; 8 (01) 494
- 25 Duan J, Gao S, Tu S, Lenahan C, Shao A, Sheng J. Pathophysiology and therapeutic potential of NADPH oxidases in ischemic stroke-induced oxidative stress. Oxid Med Cell Longev 2021; 2021: 6631805
- 26 Ye F, Zhang SY, Liu JL. et al. Research progress of regulation of PI3K/AKT signaling pathway with Yin-restoring pill. Henan Trad Chin Med 2024; 44 (03) 445-452
- 27 Zhao H, Zhai L, Wang J. et al. Ghrelin-mediated HO-1/PGC-1α signaling pathway regulates mitochondrial oxidative stress to improve traumatic brain injury in rats. J Chin Med Univ 2025; 54 (04) 351-358
- 28 Ko JH, Jung TW, Pyo MK. et al. Senkyunolide A mitigates lipid deposition in hyperlipidemic hepatocytes through SIRT6-mediated suppression of oxidative stress and fetuin-A. Biochem Biophys Res Commun 2025; 771: 152046
